Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 55


"Evaluating primary endpoints in peanut immunotherapy clinical trials".

Rodríguez Del Río P, Escudero C, Sánchez-García S, Ibáñez MD, Vickery BP.

J Allergy Clin Immunol. 2018 Oct 24. pii: S0091-6749(18)31487-8. doi: 10.1016/j.jaci.2018.09.035. [Epub ahead of print]


High- and low-dose oral immunotherapy similarly suppress pro-allergic cytokines and basophil activation in young children.

Kulis M, Yue X, Guo R, Zhang H, Orgel K, Ye P, Li Q, Liu Y, Kim E, Burks AW, Vickery BP.

Clin Exp Allergy. 2018 Aug 20. doi: 10.1111/cea.13256. [Epub ahead of print]


Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research.

Chehade M, Jones SM, Pesek RD, Burks AW, Vickery BP, Wood RA, Leung DYM, Furuta GT, Fleischer DM, Henning AK, Dawson P, Lindblad RW, Sicherer SH, Abonia JP, Sherrill JD, Sampson HA, Rothenberg ME.

J Allergy Clin Immunol Pract. 2018 Sep - Oct;6(5):1534-1544.e5. doi: 10.1016/j.jaip.2018.05.038. Epub 2018 Aug 1.


Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis.

Kottyan LC, Maddox A, Braxton JR, Stucke EM, Mukkada V, Putnam PE, Abonia JP, Chehade M, Wood RA, Pesek RD, Vickery BP, Furuta GT, Dawson P, Sampson HA, Martin LJ, Kelly JA, Kimberly RP, Sivils K, Gaffney PM, Kaufman K, Harley JB, Rothenberg ME.

Genes Immun. 2018 Jun 8. doi: 10.1038/s41435-018-0034-z. [Epub ahead of print]


Immune mechanisms of oral immunotherapy.

Kulis MD, Patil SU, Wambre E, Vickery BP.

J Allergy Clin Immunol. 2018 Feb;141(2):491-498. doi: 10.1016/j.jaci.2017.12.979. Epub 2017 Dec 26.


Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.

Bird JA, Spergel JM, Jones SM, Rachid R, Assa'ad AH, Wang J, Leonard SA, Laubach SS, Kim EH, Vickery BP, Davis BP, Heimall J, Cianferoni A, MacGinnitie AJ, Crestani E, Burks AW; ARC001 Study Group.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):476-485.e3. doi: 10.1016/j.jaip.2017.09.016. Epub 2017 Oct 31.


A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders.

Wambre E, Bajzik V, DeLong JH, O'Brien K, Nguyen QA, Speake C, Gersuk VH, DeBerg HA, Whalen E, Ni C, Farrington M, Jeong D, Robinson D, Linsley PS, Vickery BP, Kwok WW.

Sci Transl Med. 2017 Aug 2;9(401). pii: eaam9171. doi: 10.1126/scitranslmed.aam9171.


Specific allergen profiles of peanut foods and diagnostic or therapeutic allergenic products.

Filep S, Block DS, Smith BRE, King EM, Commins S, Kulis M, Vickery BP, Chapman MD.

J Allergy Clin Immunol. 2018 Feb;141(2):626-631.e7. doi: 10.1016/j.jaci.2017.05.049. Epub 2017 Jul 12.


Epicutaneous immunotherapy for the treatment of peanut allergy in children and young adults.

Jones SM, Sicherer SH, Burks AW, Leung DY, Lindblad RW, Dawson P, Henning AK, Berin MC, Chiang D, Vickery BP, Pesek RD, Cho CB, Davidson WF, Plaut M, Sampson HA, Wood RA; Consortium of Food Allergy Research.

J Allergy Clin Immunol. 2017 Apr;139(4):1242-1252.e9. doi: 10.1016/j.jaci.2016.08.017. Epub 2016 Oct 26.


Eosinophilic esophagitis during peanut oral immunotherapy with omalizumab.

Burk CM, Dellon ES, Steele PH, Virkud YV, Kulis M, Burks AW, Vickery BP.

J Allergy Clin Immunol Pract. 2017 Mar - Apr;5(2):498-501. doi: 10.1016/j.jaip.2016.11.010. Epub 2016 Dec 22. No abstract available.


Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy.

Virkud YV, Burks AW, Steele PH, Edwards LJ, Berglund JP, Jones SM, Scurlock AM, Perry TT, Pesek RD, Vickery BP.

J Allergy Clin Immunol. 2017 Mar;139(3):882-888.e5. doi: 10.1016/j.jaci.2016.07.030. Epub 2016 Sep 5.


Low dose immunotherapy in very young children to treat peanut allergy.

Vickery BP.

Expert Rev Clin Immunol. 2016 Dec;12(12):1251-1253. Epub 2016 Sep 12. No abstract available.


Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2.

Orgel KA, Duan S, Wright BL, Maleki SJ, Wolf JC, Vickery BP, Burks AW, Paulson JC, Kulis MD, Macauley MS.

J Allergy Clin Immunol. 2017 Jan;139(1):366-369.e2. doi: 10.1016/j.jaci.2016.06.053. Epub 2016 Aug 20. No abstract available.


Early oral immunotherapy in peanut-allergic preschool children is safe and highly effective.

Vickery BP, Berglund JP, Burk CM, Fine JP, Kim EH, Kim JI, Keet CA, Kulis M, Orgel KG, Guo R, Steele PH, Virkud YV, Ye P, Wright BL, Wood RA, Burks AW.

J Allergy Clin Immunol. 2017 Jan;139(1):173-181.e8. doi: 10.1016/j.jaci.2016.05.027. Epub 2016 Aug 10.


Food-specific IgG4 is associated with eosinophilic esophagitis.

Wright BL, Kulis M, Guo R, Orgel KA, Wolf WA, Burks AW, Vickery BP, Dellon ES.

J Allergy Clin Immunol. 2016 Oct;138(4):1190-1192.e3. doi: 10.1016/j.jaci.2016.02.024. Epub 2016 Apr 6. No abstract available.


Component-resolved analysis of IgA, IgE, and IgG4 during egg OIT identifies markers associated with sustained unresponsiveness.

Wright BL, Kulis M, Orgel KA, Burks AW, Dawson P, Henning AK, Jones SM, Wood RA, Sicherer SH, Lindblad RW, Stablein D, Leung DY, Vickery BP, Sampson HA; Consortium of Food Allergy Research.

Allergy. 2016 Nov;71(11):1552-1560. doi: 10.1111/all.12895. Epub 2016 Jun 13.


Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy.

Jones SM, Burks AW, Keet C, Vickery BP, Scurlock AM, Wood RA, Liu AH, Sicherer SH, Henning AK, Lindblad RW, Dawson P, Berin C, Fleischer DM, Leung DYM, Plaut M, Sampson HA; Consortium of Food Allergy Research (CoFAR).

J Allergy Clin Immunol. 2016 Apr;137(4):1117-1127.e10. doi: 10.1016/j.jaci.2015.12.1316. Epub 2016 Mar 9.


Impact of Allergic Reactions on Food-Specific IgE Concentrations and Skin Test Results.

Sicherer SH, Wood RA, Vickery BP, Perry TT, Jones SM, Leung DY, Blackwell B, Dawson P, Burks AW, Lindblad R, Sampson HA.

J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):239-45.e4. doi: 10.1016/j.jaip.2015.11.015. Epub 2015 Dec 21.


Oral Immunotherapy for Food Allergy.

Burbank AJ, Sood P, Vickery BP, Wood RA.

Immunol Allergy Clin North Am. 2016 Feb;36(1):55-69. doi: 10.1016/j.iac.2015.08.007. Review.


Current Options for the Treatment of Food Allergy.

Lanser BJ, Wright BL, Orgel KA, Vickery BP, Fleischer DM.

Pediatr Clin North Am. 2015 Dec;62(6):1531-49. doi: 10.1016/j.pcl.2015.07.015. Epub 2015 Sep 7. Review.

Supplemental Content

Loading ...
Support Center